Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Fibrobiologics Inc FBLG

Healthcare Biotechnology
FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company’s product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound healing; CYMS101 which has completed Phase 1 trial for the treatment of multiple sclerosis... see more

Current News (NDAQ:FBLG)

FibroBiologics CEO Issues Letter to Shareholders

GlobeNewswire 4 days ago

FibroBiologics Reports Preclinical Data Showing Fibroblast Spheroids May Actively Reprogram the Burn Wound Environment to Drive Healing and Reduce Scarring

GlobeNewswire 4 days ago

FibroBiologics Announces Release of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial

GlobeNewswire 5 days ago

FibroBiologics Reports Q1 2026 Financial Results and Provides Corporate Update

GlobeNewswire 8 days ago

FibroBiologics Announces Poster Presentation at the Society for Investigative Dermatology Annual Meeting 2026

GlobeNewswire 9 days ago

FibroBiologics Compliant with All Nasdaq Listing Requirements

GlobeNewswire April 20, 2026

FibroBiologics Presents Novel Thymus Organoid Platform to Combat Age-Related Immune Decline at Keystone Symposia on Aging and Immunity

GlobeNewswire April 10, 2026

FibroBiologics Announces Closing of $3 Million Public Offering

GlobeNewswire April 2, 2026

FibroBiologics Announces Pricing of $3 Million Public Offering

GlobeNewswire March 31, 2026
View More News ››

Opinion & Analysis (NDAQ:FBLG)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:FBLG)

I dumped this!

Thinking we are heading into a recession, I suspect this sector will not do well over the next little while. I may revisit this issue...
ValuePro - August 24, 2025

Overlooked sector?

The AI and other tech stocks are catching most of the investor interest for now, and they are grossly overvalued, in my opinion. That...
ValuePro - August 2, 2025

RE:RE:RE:The share price is moving nicely.

Ditto.
ValuePro - June 28, 2025

RE:RE:The share price is moving nicely.

Uh, and prices are lower still. We need news here to find support.
ValuePro - June 1, 2025

RE:The share price is moving nicely.

"The share price is moving nicely." Not lately. I waited for lower prices to start my position here. As the price got lower...
ValuePro - May 24, 2025

The share price is moving nicely.

eom
ValuePro - April 26, 2025
View more Bullboard ››

Sekur Private Data Ltd.

Sekur Private Data Ltd.

Sekur Private Data Ltd. operates as a cybersecurity and internet privacy provider of Swiss hosted solutions for secure ...
View More »

Podcasts